Reaching an initial sedation target does not guarantee that sedation remains adequate throughout a procedure.
A gastroendoscopy study compared remimazolam regimens with a propofol regimen. Induction success was reported for all groups, but completion rates were lower than one hundred percent and other recovery and adverse-event measures differed.
The three groups all had 100% induction success, while completion rates were approximately 90–93%. Average time from the last administration to discharge criteria was about sixteen minutes in the two remimazolam groups and twenty minutes in the propofol group. The starting point for that clock differs from the initial induction assessment. Combining the percentages into one success claim would erase part of the study’s finding.
The regimens included an opioid, and the findings do not isolate remimazolam from the complete treatment package. Initial and sustained endpoints had different definitions, while selected monitoring was available only in some subjects.
Report induction and completion separately. A successful initial score cannot establish uninterrupted adequacy, and later rescue treatment is not necessarily evidence of an overdose. Review the full medication sequence, responsiveness and procedure requirements when interpreting an individual sedation course.
Source: PMC11271046, supplied full-text paper. Findings are paraphrased; forensic implications are an interpretation.
Related: Phenobarbital Versus Lorazepam: All-Cause Readmission Was Different From Alcohol-Related Readmission.